INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 419m ago
HOUSE PTR19m ago
SEC 13F19m ago
ROBINHOOD CHAIN19m ago
Corporate insider
WB

Wahl Bryan

General CounselCIK 0001841401

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 3
Max Insider Score46
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
42
WB
Wahl BryanGeneral Counsel
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$283K
4,125 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Tarsus Pharmaceuticals, Inc.General Counsel · Mar 19, 2026
46
WB
Wahl BryanGeneral Counsel
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL
$284K
4,084 sh
Mar 17, 2026
Mar 19, 2026
traded Mar 17, 2026
+2d
SEC FORM 4

Evidence

42
WB
Wahl BryanGeneral Counsel
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$283K
4,231 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC FORM 4

Evidence